Drugs are molecules that alter the way neurons transmit, receive, and process messages, causing pleasure but also obstructing regular brain communication. Different medications cause various brain reactions, and they could achieve this by imitating the brain's normal neurotransmitters. Drugs like morphine and cannabis mimic natural neurotransmitters to activate nerve cells by tricking the brain's receptors. Drugs alter or magnify the messages that are sent to the brain's central nervous system when they attach to and activate neurons. Overstimulation of the brain's "reward circuit." Dopamine, a neurotransmitter associated with the brain's reward system, is released in excess as a result of drugs like cocaine and methamphetamine. Drugs strongly "reinforce the connection between the ingestion of the drug, the ensuing pleasure, and all the environmental signals associated with the event" because they cause a dopamine spike. Large dopamine surges "train" the brain to seek drugs instead of other, healthier objectives and activities. Disrupting the brain's chemical and circuitry systems that control memory, stress, behaviour, judgement, and decision-making. Even when a person is aware of the negative effects of abusing drugs or alcohol, SUD causes them to overlook these effects in their ongoing quest for drug-induced pleasure or in an effort to stave off withdrawal symptoms.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States